UnitedHealth Group Inc. (NYSE:UNH) announced a quarterly dividend on Wednesday, November 9th. Stockholders of record on Friday, December 2nd will be paid a dividend of 0.625 per share by the healthcare conglomerate on Tuesday, December 13th. This represents a $2.50 annualized dividend and a dividend yield of 1.64%. The ex-dividend date is Wednesday, November 30th.

Shares of UnitedHealth Group (NYSE:UNH) opened at 152.11 on Tuesday. The stock has a 50 day moving average price of $143.81 and a 200 day moving average price of $139.88. The stock has a market capitalization of $144.61 billion, a P/E ratio of 25.31 and a beta of 0.63. UnitedHealth Group has a one year low of $107.51 and a one year high of $154.50.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, beating the Zacks’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The firm had revenue of $46.30 billion for the quarter, compared to analysts’ expectations of $46.09 billion. During the same period last year, the firm earned $1.77 EPS. The company’s quarterly revenue was up 11.6% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group will post $8.01 earnings per share for the current year.

Dividend History for UnitedHealth Group (NYSE:UNH)

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Inc. (UNH) to Issue Quarterly Dividend of $0.63 on December 13th” was first reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2016/11/29/unitedhealth-group-inc-unh-to-issue-quarterly-dividend-of-0-63-on-december-13th.html.

In other news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP D Ellen Wilson sold 14,365 shares of the business’s stock in a transaction that occurred on Friday, October 21st. The shares were sold at an average price of $144.18, for a total value of $2,071,145.70. Following the completion of the sale, the executive vice president now directly owns 66,635 shares in the company, valued at approximately $9,607,434.30. The disclosure for this sale can be found here. Insiders own 1.65% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. AXA raised its stake in shares of UnitedHealth Group by 4.9% in the second quarter. AXA now owns 1,053,508 shares of the healthcare conglomerate’s stock worth $148,755,000 after buying an additional 49,280 shares during the last quarter. GAM Holding AG raised its stake in shares of UnitedHealth Group by 24.2% in the second quarter. GAM Holding AG now owns 285,177 shares of the healthcare conglomerate’s stock worth $40,267,000 after buying an additional 55,524 shares during the last quarter. Atlantic Trust Group LLC raised its stake in shares of UnitedHealth Group by 1.7% in the second quarter. Atlantic Trust Group LLC now owns 1,063,265 shares of the healthcare conglomerate’s stock worth $150,133,000 after buying an additional 17,444 shares during the last quarter. Van Hulzen Asset Management LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth about $104,000. Finally, Engineers Gate Manager LP raised its stake in shares of UnitedHealth Group by 634.5% in the second quarter. Engineers Gate Manager LP now owns 21,300 shares of the healthcare conglomerate’s stock worth $3,008,000 after buying an additional 18,400 shares during the last quarter. 84.92% of the stock is currently owned by institutional investors.

Several equities research analysts recently issued reports on the company. Leerink Swann reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, November 23rd. Mizuho cut UnitedHealth Group from a “buy” rating to a “neutral” rating in a report on Wednesday, November 9th. Credit Suisse Group AG reiterated an “outperform” rating and issued a $160.00 price objective (up from $155.00) on shares of UnitedHealth Group in a report on Friday, October 21st. Vetr cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $144.66 price objective on the stock. in a report on Tuesday, October 18th. Finally, Jefferies Group reiterated a “buy” rating and issued a $163.00 price objective on shares of UnitedHealth Group in a report on Sunday, October 16th. Two investment analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $158.03.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.